Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Michiel Van Oort"'
Publikováno v:
Journal of Aerosol Science. 37:1520-1531
A series of standardized entrainment tubes (SETs) were designed to provide a method for evaluation of aerosol dispersion of pharmaceutical powders. The range of specific resistances ( R D ) provided by the SETs encompassed those of commercial DPIs. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed32cca89b31c3c6096c1e9a65c2c4d6
https://doi.org/10.1016/j.jaerosci.2006.04.002
https://doi.org/10.1016/j.jaerosci.2006.04.002
Publikováno v:
Pharmaceutical Research. 21:1200-1206
Purpose. To examine the effect of particle size and morphology on aerosol dispersion using jet-milled and spray-dried mannitol particles in narrow size distributions within the respirable range. Methods. Particle size and morphology were examined by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2056111c17919cbfe126cbc6b4cb08ac
https://doi.org/10.1023/b:pham.0000033007.27278.60
https://doi.org/10.1023/b:pham.0000033007.27278.60
Autor:
Nicholas C. Miller, Francisco J. Romay, Michael J. Holroyd, Hochrainer Dieter, Bo Olsson, Daryl L. Roberts, Jolyon P. Mitchell, Michiel Van Oort, Virgil A. Marple, Keith G. Truman
Publikováno v:
Journal of Aerosol Medicine. 16:283-299
A new cascade impactor has been designed specifically for pharmaceutical inhaler testing. This impactor, called the Next Generation Pharmaceutical Impactor (NGI), has seven stages and is intended to operate at any inlet flow rate between 30 and 100 L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8aee3e60a7f47a1961974f7b6b97c35
https://doi.org/10.1089/089426803769017659
https://doi.org/10.1089/089426803769017659
Autor:
Michiel Van Oort
Publikováno v:
Aerosol Science and Technology. 22:364-373
There is increasing focus on the development of dry powder inhalers (DPIs) for the delivery of therapeutic entities to the lungs. In vitro testing of metered-dose inhalers (MDIs) has evolved through the years and general tests and methods have been p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3018a5718e82461a29df9867236ca408
https://doi.org/10.1080/02786829408959754
https://doi.org/10.1080/02786829408959754
Publikováno v:
Pharmaceutical Research. 11:604-607
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de6d84b099d4def707ddaea2e80a7c2b
https://doi.org/10.1023/a:1018995322555
https://doi.org/10.1023/a:1018995322555
Autor:
Svetlana Lyapustina, Jolyon P. Mitchell, Dave Christopher, Richard Bauer, Volker Glaab, Terrence P. Tougas, Michiel Van Oort
Over the lifecycle of an orally inhaled product (OIP), multi-stage cascade impactor (CI) measurements are used for different purposes and to address different questions. Full-resolution CIs can provide important information during product development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21901be790a18d0d4cd4fdd151462795
https://europepmc.org/articles/PMC3066373/
https://europepmc.org/articles/PMC3066373/
Autor:
Mark Sacchetti, Michiel Van Oort
Publikováno v:
Inhalation Aerosols ISBN: 9780429131851
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cd81fb501f0fac6e73ee2943d71ebbf
https://doi.org/10.3109/9781420019537-15
https://doi.org/10.3109/9781420019537-15
Publikováno v:
Pharmaceutical research. 21(7)
To examine the effect of formulation type on the aerosolization of respirable particles in narrow size distributions.Aerosol dispersion of two formulation types (drug alone and 2% w/w drug-lactose blends) containing micronized or spray-dried fluticas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14cf5e34fbea861cb36a888fe20d8f2
https://pubmed.ncbi.nlm.nih.gov/15290861
https://pubmed.ncbi.nlm.nih.gov/15290861
Autor:
Michiel Van Oort, Keith G. Truman
Publikováno v:
Journal of Aerosol Medicine. 11:S-89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd0c052d7ee3cecd0df64e8d83fd5354
https://doi.org/10.1089/jam.1998.11.suppl_1.s-89
https://doi.org/10.1089/jam.1998.11.suppl_1.s-89
Publikováno v:
Pharmaceutical Research; Jul2004, Vol. 21 Issue 7, p1207-1213, 7p